Published in J Steroid Biochem Mol Biol on August 01, 1994
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest (1996) 3.44
Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest (1992) 3.40
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res (1995) 3.23
Two cis-acting elements in the 3' untranslated region of alpha-CaMKII regulate its dendritic targeting. Nat Neurosci (2000) 2.34
Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res (1993) 2.24
Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol (1999) 2.14
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res (1995) 1.97
Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci U S A (1993) 1.92
Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol (2000) 1.77
Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis (1994) 1.76
In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature (1981) 1.71
A double blind placebo controlled crossover study of prostacyclin in man. Life Sci (1979) 1.67
Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. N Engl J Med (1981) 1.61
Inhibition of hemolytic activity of the thermostable direct hemolysin of Vibrio parahaemolyticus by ganglioside. Infect Immun (1975) 1.61
Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood (2000) 1.59
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res (2001) 1.57
Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis (1985) 1.55
Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem (1998) 1.54
The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest (1995) 1.53
Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest (1997) 1.52
Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene (2001) 1.51
First sporadic cases of non-pneumonic legionellosis, Pontiac fever in Japan. Intern Med (1998) 1.40
Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol (1996) 1.36
Monocytes regulate osteoclast-activating factor production by releasing prostaglandins. J Exp Med (1979) 1.32
Changes in hardness of the human elbow flexor muscles after eccentric exercise. Eur J Appl Physiol (2000) 1.31
alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. Oncogene (1999) 1.31
E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res (1996) 1.30
Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine. N Engl J Med (1983) 1.29
A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency. Metabolism (1989) 1.28
Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone (2002) 1.26
Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations. J Biol Chem (2001) 1.21
Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol (1993) 1.19
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest (1994) 1.18
Osteogenesis by chondrocytes from growth cartilage of rat rib. Calcif Tissue Res (1975) 1.18
Bisphosphonates as anticancer drugs. N Engl J Med (1998) 1.18
Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem (1994) 1.18
The unfolded protein response and Alzheimer's disease. Biochim Biophys Acta (2001) 1.17
Chemo-taxonomical studies on fatty acids of "Brucella" species. Ann Sclavo (1977) 1.16
Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther (2001) 1.15
Congenital collateral urethral duplication in the frontal plane. J Urol (1999) 1.14
Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy. Cancer Res (2001) 1.13
Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res (2000) 1.13
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol (2009) 1.12
Treatment of ruptured hepatocellular carcinoma. Int J Clin Oncol (2001) 1.12
Serological studies of antigenic similarity between Japanese spotted fever rickettsiae and Weil-Felix test antigens. J Clin Microbiol (1992) 1.11
Sialyl SSEA-1 antigen as a carbohydrate marker of human natural killer cells and immature lymphoid cells. Blood (1989) 1.11
The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro. J Clin Endocrinol Metab (1993) 1.11
Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J Biol Chem (2000) 1.10
Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption. J Cell Physiol (1998) 1.10
Increased plasma endothelin levels in Kawasaki disease: a possible marker for Kawasaki disease. Angiology (1993) 1.10
Tuberculosis of the tongue. A case report with immunologic study. Oral Surg Oral Med Oral Pathol (1979) 1.09
[The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis]. Kekkaku (1997) 1.09
Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab (2000) 1.08
Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment. Semin Oncol (2001) 1.05
The reactivity between rickettsiae and Weil-Felix test antigens against sera of rickettsial disease patients. Acta Virol (1992) 1.05
c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene (2010) 1.05
Factors regulating the growth of metastatic cancer in bone. Endocr Relat Cancer (1999) 1.04
Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes (1981) 1.02
Severe complications of mediastinal pancreatic pseudocyst: report of esophagobronchial fistula and hemothorax. J Hepatobiliary Pancreat Surg (2000) 1.02
Calcitonin and parathyroid-hormone stimulation of acid mucopolysaccharide synthesis in cultured chondrocytes isolated from growth cartilage. FEBS Lett (1976) 1.02
Evidence that glycine and GABA mediate postsynaptic inhibition of bulbar respiratory neurons in the cat. J Appl Physiol (1985) (1992) 1.01
Neuropharmacology of control of respiratory rhythm and pattern in mature mammals. Pharmacol Ther (2000) 1.01
Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. Atherosclerosis (1981) 1.01
A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res (1992) 1.01
Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Cancer Res (1985) 0.99
PRKAR1A gene mutation in patients with cardiac myxoma. Int J Cardiol (2005) 0.98
Mesenchymal cells from the human embryonic palate are highly responsive to epidermal growth factor. Science (1981) 0.98
Mechanisms of FK 506-induced hypertension in the rat. Hypertension (1999) 0.98
Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet (1994) 0.97
Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia. Metabolism (1978) 0.97
Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels (1985) 0.97
Molecular cloning of a novel membrane glycoprotein, pal, specifically expressed in photoreceptor cells of the retina and containing leucine-rich repeat. J Neurosci (2000) 0.96
Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology (2000) 0.96
Homozygous familial hypercholesterolemia in Japan. Am J Med (1978) 0.96
Effects of glycine and GABA on bulbar respiratory neurons of cat. J Neurophysiol (1990) 0.96
Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes. J Exp Med (1979) 0.96
Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation (1981) 0.96
Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res (1998) 0.96
Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan. J Endocrinol Invest (1995) 0.96
Thrombolytic therapy for cerebral embolism. Interv Neuroradiol (2001) 0.96
Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis. Am J Surg (1980) 0.96
Usefulness of ultrasonography and Doppler color flow imaging in the diagnosis of internal jugular phlebectasia. Heart Vessels (1992) 0.95
False aneurysm of a digital artery in a softball catcher evaluated by sonography: a case report. J Trauma (1996) 0.95
Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium. Circulation (2000) 0.95
Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells. Invest New Drugs (2001) 0.95
[Study on correlation between chest X-P course findings and change in antinuclear antibody in asbestos plant employees]. Sangyo Eiseigaku Zasshi (1996) 0.94
Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7. Biochem Biophys Res Commun (1995) 0.94
Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer (2013) 0.94
The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus. J Clin Endocrinol Metab (2001) 0.93
Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab (1996) 0.93
Prostacyclin stimulates the renin angiotensin aldosterone system in man. J Clin Endocrinol Metab (1979) 0.93
Cardiac characteristics and postoperative courses in Cushing's syndrome. Am J Cardiol (1992) 0.93